InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Naftzger J. Christopher, Dirigeant. Director active across 1 company, notably Nabriva Therapeutics plc. Aggregated, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €7k. Activity tracked since 27 December 2021. The latest transaction was filed on 27 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
7,000 shares@ US$0.59100.0% of flowOrdinary SharesSEC:0001104659-21-154012
Ideal exit: 23 Sept 2022 (T+270)
7,000 shares@ US$0.5950.0% of flowOrdinary SharesSEC:0001104659-21-154012:0
Ideal exit: 23 Sept 2022 (T+270)
2 of 2 declarations
About Naftzger J. Christopher
J. Christopher Naftzger is General Counsel and Corporate Secretary of Nabriva Therapeutics plc. He oversees the legal affairs and regulatory compliance of the company, ensuring its good governance.
